Related Experiment Video
Updated: Jun 3, 2026
07:03
Mouse Oocyte Microinjection, Maturation and Ploidy Assessment
Published on: July 23, 2011
Trisomic pregnancy and elevated FSH: implications for the oocyte pool hypothesis.
J K Kline1, A M Kinney, B Levin
1Imprints Center, New York State Psychiatric Institute, New York, NY 10032, USA. jkk3@columbia.edu
Human Reproduction (Oxford, England)
|April 7, 2011
Summary
Elevated follicle-stimulating hormone (FSH) may indicate increased trisomy risk in pregnancy, potentially linked to oocyte pool size. Anti-Müllerian hormone (AMH) levels did not show a similar association.
Area of Science:
- Reproductive Endocrinology
- Genetics
- Maternal-Fetal Medicine
Background:
- Trisomy frequency may correlate with oocyte pool size, with higher risk in women with diminished ovarian reserve.
- Hormonal indicators of ovarian age, including anti-Müllerian hormone (AMH), follicle-stimulating hormone (FSH), and inhibin B, are used to assess ovarian reserve.
Purpose of the Study:
- To investigate the relationship between hormonal indicators of ovarian age and the occurrence of trisomic pregnancy losses.
- To compare hormonal profiles of women with trisomic losses to those with non-trisomic losses and chromosomally normal live births.
Main Methods:
- A case-control study utilizing data from two hospital-based cohorts.
- Comparison of hormonal measures (AMH, FSH, inhibin B) between 159 women with trisomic losses and three control groups (other abnormal losses, normal losses, live births).
- Statistical analyses adjusted for maternal age, day of blood draw, storage interval, and study site.
Main Results:
- Anti-Müllerian hormone (AMH) and inhibin B levels did not differ significantly between women with trisomic losses and any control group.
- Mean follicle-stimulating hormone (FSH) levels were significantly higher in women with trisomic losses compared to live birth controls (adjusted odds ratio: 3.8).
- Elevated FSH was also observed in trisomy cases compared to other chromosomally abnormal and normal loss groups, though not always reaching statistical significance.
Conclusions:
- The association between trisomy and elevated FSH supports the oocyte pool hypothesis, suggesting a potential link between diminished ovarian reserve and trisomy risk.
- The lack of association with AMH suggests alternative or additional mechanisms may be involved.
- Elevated FSH could potentially disrupt oocyte meiosis or follicle development, contributing to trisomy occurrence.
More Related Videos
Related Concept Videos
02:07Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
01:22Oogenesis
Oogenesis, the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is known...
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is known...
01:27Ovarian Cycle
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
01:57Meiosis II
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each containing...
01:21Nondisjunction
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
01:29Nondisjunction
During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.